Prediction of Adjuvant Gemcitabine Sensitivity in Resectable Pancreatic Adenocarcinoma Using the GemPred RNA Signature: An Ancillary Study of the PRODIGE-24/CCTG PA6 Clinical Trial
利用 GemPred RNA 特征预测可切除胰腺腺癌辅助吉西他滨敏感性:PRODIGE-24/CCTG PA6 临床试验的辅助研究
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.22.02668
Nicolle, Rémy; Bachet, Jean-Baptiste; Harlé, Alexandre; Iovanna, Juan; Hammel, Pascal; Rebours, Vinciane; Turpin, Anthony; Ben Abdelghani, Meher; Wei, Alice; Mitry, Emmanuel; Lopez, Anthony; Biagi, James; François, Eric; Artru, Pascal; Lambert, Aurélien; Renouf, Daniel J; Monard, Laure; Mauduit, Marjorie; Dusetti, Nelson; Conroy, Thierry; Cros, Jérome